Insider · CIK 0001844594

Weber Steven

Reports to the SEC for 3 companies · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001844594

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-14	PLSEPULSE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+55K sh	—	—	55,000
2025-06-16	IGM Biosciences, Inc.S Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−486 sh	$1.20	−$582.811	26,530
2025-05-14	IGM Biosciences, Inc.S Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−1,865 sh	$1.12	−$2,089.919	27,016
2025-03-14	IGM Biosciences, Inc.S Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−1,701 sh	$1.23	−$2,092.23	28,881
2025-01-15	IGM Biosciences, Inc.S Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−1,122 sh	$1.70	−$1,907.288	30,582
2024-12-16	IGM Biosciences, Inc.S Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−539 sh	$7.48	−$4,031.72	31,704
2024-11-07	IGM Biosciences, Inc.A Award	PRINCIPAL ACCOUNTING OFFICER	AAward	+6,700 sh	—	—	32,243
2024-09-13	IGM Biosciences, Inc.S Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−469 sh	$11.54	−$5,411.697	25,543
2024-06-14	IGM Biosciences, Inc.S Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−495 sh	$7.58	−$3,749.774	26,012
2024-03-14	IGM Biosciences, Inc.S Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−464 sh	$10.17	−$4,719.112	26,507
2024-03-13	IGM Biosciences, Inc.S Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−529 sh	$9.88	−$5,223.981	26,971
2024-03-12	IGM Biosciences, Inc.A Award	PRINCIPAL ACCOUNTING OFFICER	AAward	+18.8K sh	—	—	27,500
2024-03-12	IGM Biosciences, Inc.Stock Option (right to buy)A Award	PRINCIPAL ACCOUNTING OFFICER	AAward	+37.5K sh	—	—	37,500
2023-04-04	IGM Biosciences, Inc.A Award	PRINCIPAL ACCOUNTING OFFICER	AAward	+8,750 sh	—	—	8,750
2023-04-04	IGM Biosciences, Inc.Stock Option (right to buy)A Award	PRINCIPAL ACCOUNTING OFFICER	AAward	+17.5K sh	—	—	17,500
2022-02-17	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	VP, Controller&Princ Acctg Off	AAward	+30K sh	—	—	30,000
2021-02-17	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	VP, Controller&Princ Acctg Off	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Jul 164
Weber Steven0001437749-25-022853
SEC(opens sec.gov)
Jun 204
Weber Steven0001415889-25-017916
SEC(opens sec.gov)
May 164
Weber Steven0001415889-25-013410
SEC(opens sec.gov)
Mar 184
Weber Steven0001415889-25-008521
SEC(opens sec.gov)
Jan 174
Weber Steven0001415889-25-001715
SEC(opens sec.gov)
Dec 184
Weber Steven0001415889-24-029779
SEC(opens sec.gov)
Nov 124
Weber Steven0001415889-24-026651
SEC(opens sec.gov)
Sep 174
Weber Steven0001415889-24-023589
SEC(opens sec.gov)
Jun 184
Weber Steven0001415889-24-017501
SEC(opens sec.gov)
Mar 154
Weber Steven0001415889-24-008174
SEC(opens sec.gov)
Mar 144
Weber Steven0001415889-24-008058
SEC(opens sec.gov)
Apr 64
Weber Steven0001209191-23-023706
SEC(opens sec.gov)
Feb 224
Weber Steven0001209191-22-011718
SEC(opens sec.gov)
Feb 194
Weber Steven0001209191-21-012429
SEC(opens sec.gov)

Companies

Address

C/O IGM BIOSCIENCES, INC. 325 E. MIDDLEFIELD ROAD

MOUNTAIN VIEW, CA, 94043